Kevin Craig

About

Kevin Craig became Chief Medical Officer of atai Life Sciences in 2025, having joined in 2021 as Vice President and later Senior Vice President of Clinical Development, where he oversees clinical development, regulatory affairs, drug safety, biostatistics, and global clinical operations. He has more than 20 years of clinical experience with a focus on neuroscience pipelines, and previously held a faculty appointment at the University of Cambridge's Behavioral and Clinical Neuroscience Institute and worked at P1vital on imaging and cognitive biomarkers for early-phase psychiatry trials. He earned his medical degree from the University of Witwatersrand and an MPhil in Medical Science from the University of Cambridge, and is a member of the Royal College of Psychiatrists with accreditation in addiction and adult psychiatry.